ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 178 filers reported holding ARENA PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 1.31 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $40,529,000 | +59.8% | 436,072 | +2.4% | 0.01% | +50.0% |
Q3 2021 | $25,367,000 | -11.5% | 425,977 | +1.3% | 0.01% | -20.0% |
Q2 2021 | $28,666,000 | +1.5% | 420,316 | +3.3% | 0.01% | 0.0% |
Q1 2021 | $28,239,000 | -4.3% | 406,955 | +6.0% | 0.01% | -16.7% |
Q4 2020 | $29,497,000 | +4.6% | 383,925 | +1.8% | 0.01% | -7.7% |
Q3 2020 | $28,208,000 | +20.2% | 377,157 | +1.2% | 0.01% | +18.2% |
Q2 2020 | $23,473,000 | +75.9% | 372,868 | +17.4% | 0.01% | +37.5% |
Q1 2020 | $13,343,000 | -16.7% | 317,682 | -9.9% | 0.01% | -11.1% |
Q4 2019 | $16,022,000 | -0.6% | 352,744 | +0.2% | 0.01% | -10.0% |
Q3 2019 | $16,111,000 | -18.0% | 351,978 | +5.0% | 0.01% | -16.7% |
Q2 2019 | $19,656,000 | +54.1% | 335,245 | +17.9% | 0.01% | +50.0% |
Q1 2019 | $12,753,000 | +20.8% | 284,467 | +5.0% | 0.01% | 0.0% |
Q4 2018 | $10,554,000 | -15.9% | 270,962 | -0.6% | 0.01% | 0.0% |
Q3 2018 | $12,551,000 | +12.2% | 272,715 | +6.3% | 0.01% | 0.0% |
Q2 2018 | $11,190,000 | +30.0% | 256,650 | +17.8% | 0.01% | +14.3% |
Q1 2018 | $8,608,000 | +21.2% | 217,910 | +4.2% | 0.01% | +16.7% |
Q4 2017 | $7,103,000 | +55.3% | 209,085 | +16.6% | 0.01% | +50.0% |
Q3 2017 | $4,574,000 | +106.2% | 179,353 | +36.4% | 0.00% | +100.0% |
Q2 2017 | $2,218,000 | – | 131,465 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HUNTINGTON NATIONAL BANK | 1 | $0 | 0.00% |
IFP Advisors, Inc | 2 | $1,000 | 0.00% |